SCHEDULE 13DAccepted Oct 2, 5:36 PM ET
ADARx Pharmaceuticals, Inc. SCHEDULE 13D
Accepted (ET)
5:36 PM
Oct 2, 2026
Filed
Oct 2, 2026
Documents
2
Size
42.2 KB
Summary
Summary not available
This filing does not have a written summary yet. You can still open the original filing and its exhibits.